Fisiopatología de la migraña: Teoría vascular, ¿Cierta o no?
PDF
HTML

Palabras clave

Migraña
Péptido relacionado con el gen de la calcitonina (PRGC)
Sistema trigémino
sensibilización
glutamato
inflamación neurogénica
teoría vascular (DeCS)

Resumen

La migraña es una enfermedad de alta prevalencia, incapacitante y en algunas ocasiones de difícil manejo. Desde hace décadas se han planteado múltiples teorías para explicar su curso, su componente genético y la asociación a distintos factores de riesgo. Actualmente se desconoce una fisiopatología única y exacta que implique los eventos, y se ha encontrado fuerte evidencia que muestra que la teoría más antigua y con mayor sustento, a saber la teoría vascular, es en realidad incorrecta, pues no explica la totalidad de los eventos. Sin embargo, se han probado distintos mecanismos que, en conjunto, permiten comprender las alteraciones presentes. Entre estas se cuentan cambios estructurales, implicación de neuropéptidos, sensibilización, e inflamación neurogénica.

https://doi.org/10.22379/2422402213
PDF
HTML

Citas

GOADSBY P, OSHINSKY M. Pathophysiology of Headache. In Wolff s Hedadache and Other Head Pain. Silberstein S, Lipton RB, Dodick DW eds. 8Th Edition. New York: Oxford University Press; 2008. 7; p. 105-119.

LANCE JW, GOADSBY PJ. Mechanism and management of headache. 7th edition. New York: Elsevier; 2005.

FERRARI MD, GOADSBY PJ. Migraine as a cerebral ionopathy with abnormal central sensory processing. In: Gilman S, editor. Neurobiology of disease. New York: Elsevier; 2007. p. 333-48.

SILBERSTEIN SD, LIPTON RB, GOADSBY PJ. Headache in clinical practice. 2nd edition. London: Martin Dunitz; 2002.

JOUTEL A, DUCROS A, VAHEDI K, ET AL. Genetic heterogeneity of familial hemiplegic migraine. Am J Hum Genet 1994; 55:1166-72.

OPHOFF RA, RV EIJK, SANDKUIJL LA, ET AL. Genetic heterogeneity of familial hemi- plegic migraine. Genomics 1994; 22:21-6.

KRUIT MC, LAUNER LJ, FERRARI MD, VAN BUCHEM MA. Brain stem and cerebellar hyperintense lesions in migraine. Stroke 2006; 37:1109-12.

NOZARI A, DILEKOZ E, SUKHOTINSKY I, ET AL. Microemboli may link spreading depression, migraine aura and patent foramen ovale. Ann Neurol 2009; published online Sept 14. DOI:10.1002/ana.21871.

TIETJEN GE, AL-QASMI MM, ATHANAS K, DAFER RM, KHUDER SA. Increased von Willebrand factor in migraine. Neurology 2001; 57:334-36.

CESAR JM, GARCIA-AVELLO A, VECINO AM, SASTRE JL,ALVAREZ-CERMENO JC. Increased levels of plasma von Willebrand factor in migraine crisis. Acta Neurol Scand 1995; 91:41-13.

BARTSCH T, LEVY MJ, KNIGHT YE, ET AL. Differential modulation of nociceptive dural input to [hypocretin] Orexin A and B receptor activation in the posterior hypothalamic area. Pain 2004;109:367-78.

SCHOONMAN GG, VAN DER GROND J, KORTMANN C, ET AL. Migraine headache is not associated with cerebral or meningeal vasodilatation-a 3T magnetic resonance angiography study. Brain 2008;131:2192-200.

AMIN FM, ASGHAR MS, HOUGAARD A, ET AL. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study. Lancet Neurol 2013; 12:454-61.

HOLLAND P, GOADSBY P. The hypothalamic orexinergic system: Pain and Primary Headaches. Headache-Current Headache 2007:951-962.

OLESEN J, BURSTEIN R, ASHINA M, TFELT-HANSEN P. Origin of pain in migraine: Evidence of peripheral sensitization. Lancet Neurol 2009; 9:679- 690.

WAEBER C. Serotonin and other biogenic Amines. En Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KWA eds. The Headaches, 3rd Ed. Philadelphia: Lippincott-Williams and Wilkins; 2006. Chapter 14; p. 143-149.

HAMEL E. Serotonin and migraine: Biology and Clinical implications. Cephalalgia- Headache Currents. 2007; 27:1295-1300.

ZARCO LA, PRETELT F, MILLAN S. Sistema Trigémino Vascular y Cefalea. Univ. Med 2013; 54(1): 92-103.

AFRIDI SK, GIFFIN NJ, KAUBE H, FRACKOWIAK RS, GOADSBY PJ. A PET study in spontaneous migraine. Arch Neurol 2005; 62: 1270-1275.

GUPTA S, NAHAS SJ, PETERLIN L. Chemical mediators of migraine: Preclinical and clinical observations. Headache 2011; Headache Currents: 1029- 1045.

JOHNSON KW, BOLAY H. Neurogenic inflammatory mechanisms. In Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KWA eds. The Headaches, 3rd Ed. Philadelphia: Lippincott-Williams and Wilkins; 2006. Chapter 33; p. 309-319.

GEPPETTI P, ROSSI E, CHIARUGI A, BENEMEI S. Antidromic vasodilation and the migraine mechanism. J Headache Pain 2012; 13:103-111.

PALM-MEINDERS IH, KOPPEN H, TERWINDT GM, ET AL. Structural brain changes in migraine. JAMA 2012; 308:1889-97.

BORSOOK D, MALEKI N, BECERRA L, ET AL. Understanding migraine through the lens of maladaptive stress responses: a model disease of allostatic load. Neuron 2012; 73:219-34.

EIKERMANN-HAERTER K, LEE JH, YUZAWA I, ET AL. Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations. Circulation 2012; 125:335-45.

MESSINA, MARIA A ROCCA, Cortical abnormalities in patients with migraine: a surface- based analysis. Radiology 2013; 268(1): 170-180.

BAHRA A, MATHARU MS, BUCHEL C, FRACKOWIAK RS, GOADSBY PJ. Brainstem activation specific to migraine headache. Lancet 2001; 357:1016-7.

MARK A LOUTER, JOHANNEKE E BOSKER, WILLEBRORDUS P J VAN OOSTERHOUT. Cutaneous allodynia as a predictor of migraine chronification. Brain 2013: 136: 3489 - 3496.

VOLCY M, Fisiopatología de la migraña, Acta Neurol Colomb 2013;29:44-52.

SUNEDELSTEIN C, MAUSKOP A. Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother. 2009? 9(3):36979.

TIETJEN GE Migraine as a systemic vasculopathy. Cephalalgia 2009; 29:989-96.

BUSE DC, MANACK A, SERRANO D, TURKEL C, LIPTON RB. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers. J Neurol Neurosurg Psychiatry February 17, 2010.

VOLCY M. Pathophysiology of chronic migraine. Acta Neurol Colomb 2013;29:1 (Supl 1:1)25-30).

Martins Oliveira A, Speciali JG, Dach F, Marcaccini AM, Gonçalves FM, Gerlach RF, et al. Different circulating metalloproteinases profiles in women with migraine with and without aura. Clin Chim Acta. 2009, Oct?408(12): 604.

SOBRINO F, RAMOS M. Factores genéticos de la migraña. Acta Neurol Colomb 2013; 29:1 (Supl 1:1): 31-42.

ISAZA R, PINEDA D, AGUIRRE D, GALLEGO C. Caracterización clínica y de conglomerados de clases latentes de la migraña familiar en el aislado genético de Antioquia. Act Neurol Colomb 2008; 24:24-32.

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Descargas

Los datos de descargas todavía no están disponibles.